1,282
Views
38
CrossRef citations to date
0
Altmetric
Research Papers

Enteric trimethyl chitosan nanoparticles containing hepatitis B surface antigen for oral delivery

, &
Pages 2811-2818 | Received 10 Dec 2014, Accepted 18 May 2015, Published online: 16 Sep 2015

References

  • Franco E, Bagnato B, Marino MG, Meleleo C, Serino L, Zaratti L. Hepatitis B: Epidemiology and prevention in developing countries. World J Hepatol 2012; 4(3):74-80.
  • Liaw YF, Kao JH, Piratvisuth T, Henry L, Chien RN, Liu CJ, Gane Ed, Stephen L, Lim SG, Han KH, et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update. Hepatol Int 2012; 6(3):531-61; PMID:19669255; http://dx.doi.org/10.1007/s12072-012-9365-4.
  • El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 2012; 142(6):1264-73; PMID:22537432; http://dx.doi.org/10.1053/j.gastro.2011.12.061.
  • Zidan A, Scheuerlein H, Schüle S, Settmacher U, Rauchfuss F. Epidemiological pattern of hepatitis B and hepatitis C as etiological agents for hepatocellular carcinoma in iran and worldwide. Hepat Mon 2012: 12(10 HCC):e6894; PMID:23233864; http://dx.doi.org/10.5812/hepatmon.6894.
  • European Association for the Study of the Liver. EASL clinical practice guidelines: management of chronic hepatitis B virus infection. J Hepatol 2012; 57(1):167-85; PMID:22436845; http://dx.doi.org/10.1016/j.jhep.2012.02.010.
  • Hayden CA, Streatfield SJ, Lamphear BJ, Fake GM, Keener TK, Walker JH, Clements JD, Turner DD, Tizard IR, Howard JA, Bioencapsulation of the hepatitis B surface antigen and its use as an effective oral immunogen. Vaccine 2012; 30(19):2937-42; PMID:22406456; http://dx.doi.org/10.1016/j.vaccine.2012.02.072.
  • Khafagy ES, Morishita M, Onuki Y, Takayama K. Current challenges in non-invasive insulin delivery systems: a comparative review. Adv Drug Deliv 2007; 59:1521-46; http://dx.doi.org/10.1016/j.addr.2007.08.019.
  • Makhlof A, Tozuka U, Takeuchi H. Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery. Eur J Pharm Sci 2011; 42:445-51; PMID:21182939; http://dx.doi.org/10.1016/j.ejps.2010.12.007.
  • Amidi M, Mastrobattista E, Jiskoot W, Hennink WE. Chitosan-based deliver systems for protein therapeutics and antigens. Adv Drug Deliv Rev 2012; 62:59-82; PMID:19925837; http://dx.doi.org/10.1016/j.addr.2009.11.009.
  • Jintapattanakit A., Junyaprasert V, Mao S, Sitterberg J, Bakowsky U, Kissel T. Peroral delivery of insulin using chitosan derivatives. A comparative study of polyelectrolyte nanocomplexes and nanoparticles. Int J Pharm 2007; 342:240-9; PMID:17597316; http://dx.doi.org/10.1016/j.ijpharm.2007.05.015.
  • Mao S, Bakowsky U, Jintapattanakit A, Kissel T. Self-assembled polyelectrolyte nanocomplexes between chitosan derivatives an insulin. J Pharm Sci 2006; 95:1035-48; PMID:16565978; http://dx.doi.org/10.1002/jps.20520.
  • Bayat A, Dorkoosh FA, Dehpour AR, Moezi L, Larijani B, Junginger HE, Rafiee-Tehrani M. Nanoparticles of quaternized chitosan derivatives as a carrier for colon delivery of insulin: ex vivo and in vivo studies. Int J Pharm 2008; 356:259-66; PMID:18289808; http://dx.doi.org/10.1016/j.ijpharm.2007.12.037.
  • Philip AK, Philip B. Colon targeted drug delivery systems: a review on primary and novel approaches. Oman Med J 2010; 25(2):79-87; PMID:22125706; http://dx.doi.org/10.5001/omj.2010.24.
  • Kokubo H, Obara S, Minemura K, Tanaka T. Development of cellulose derivatives as novel enteric coating agents soluble at pH 3.5–4.5 and higher. Chem Pharm Bull 1997; 45:1350-3; PMID:9301034; http://dx.doi.org/10.1248/cpb.45.1350.
  • van der Merwe SM, Verhoef JC, Verheijden JHM, Kotze´ AF, Junginger HE. Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs. Eur J Pharm Biopharm 2004; 58:225-35; PMID:15296951; http://dx.doi.org/10.1016/j.ejpb.2004.03.023.
  • Thanou M, Verhoef JC, Romeijn SG, Nagelkerke JF, Merkus FWHM, Junginger HE. Effects of N-trimethyl chitosan chloride, a novel absorption enhancer, on Caco-2 intestinal epithelia and the ciliary beat frequency of chicken embryo trachea. Int J Pharm 1999; 185:73-82; PMID:10425367; http://dx.doi.org/10.1016/S0378-5173(99)00126-X.
  • Snyman D, Hamman JH, Kotze´ AF, Evaluation of the mucoadhesive properties of N-trimethyl chitosan chloride. Drug Dev Ind Pharm. 2003; 29:59-67; http://dx.doi.org/10.1081/DDC-120016684.
  • Amidi M, Mastrobattista E, Jiskoot W, Hennink WE, Chitosan-based delivery systems for protein therapeutics and antigens. Adv Drug Deliv Rev 2010; 62:59-82; PMID:19925837; http://dx.doi.org/10.1016/j.addr.2009.11.009.
  • Mohammadpour Dounighi, N, Eskandari R, Avadi MR, Zolfagharian H, Mir Mohammad Sadeghi A, Rezayat M, Preparation and in vitro characterization of chitosan nanoparticles containing Mesobuthus eupeus scorpion venom as an antigen delivery system. J Venomous Animals Toxins Including Tropical Dis 2012; 18(1):44-52.
  • Mourya VK, Nazma NI. Trimethyl chitosan and its applications in drug delivery. J Mater Sci Mater Med 2009; 20:1057-79 ; PMID:19112609.
  • Sharma M, Sharma V, Panda AK, Majumdar DK, Enteric microsphere formulations of papain for oral delivery. Yakugaku Zasshi. 2011; 131(5):697-709; PMID:21532266; http://dx.doi.org/10.1248/yakushi.131.697.
  • George M., Abraham T.E. Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan – a review. J Control Release 2014 114,1-14; http://dx.doi.org/10.1016/j.jconrel.2006.04.017.
  • Xiong X, Li Y, Li Z, Zhou C, Tam K, Liu Z, Xie G. Vesicles from Pluronic/poly(lactic acid) block copolymers as new carriers for oral insulin delivery, J. Control Release 2007; 120:11-7; PMID:17509718; http://dx.doi.org/10.1016/j.jconrel.2007.04.004.
  • Almeida A, Souto E. Solid lipid nanoparticles as a drug delivery system for peptides and proteins. Adv Drug Deliv Rev 2007; 59:478-90; PMID:17543416; http://dx.doi.org/10.1016/j.addr.2007.04.007.
  • Thanoua MM, Kotze´ A, Scharringhausena FT, Lueßenc H.L, Boerd A.Gde, Verhoefa J.C, Jungingera H.E. Effect of degree of quaternization of N-trimethyl chitosan chloride for enhanced transport of hydrophilic compounds across intestinal Caco-2 cell monolayers, J Control Release 2000; 64:15-25; PMID:10640642; http://dx.doi.org/10.1016/S0168-3659(99)00131-5.
  • Sieval AB, Thanou M, Kotze´ AF, Verhoef JC, Brussee J, Junginger HE. Preparation and NMR-characterization of highly substituted N-trimethyl chitosan chloride, Carbohydr. Polym. 1998; 36:157-65.
  • Mohammadpour Dounighi N, Damavandi M, Zolfagharian H, Moradi S. Preparing and characterizing chitosan nanoparticles Containing Hemiscorpius lepturus scorpion venom as an antigen delivery system, Archives of Razi Institute 2012; 67(2):145-53.
  • Bradford M. A Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248-54; PMID:942051; http://dx.doi.org/10.1016/0003-2697(76)90527-3.
  • Kruger N. The Bradford method for protein quantitation. Methods Mol Biol 1994; 32:9-15; PMID:7951753.
  • Saraei F, Mohamadpour Dounighi N, Zolfagharian H, Moradi Bidhendi S, Khaki P, Inanlou F. Design and evaluate alginate nanoparticles as a protein delivery system. Archives of Razi Institute 2013; 68(2):139-46.
  • Sarei F, Mohammadpour Dounighi N,Zolfagharian H, Khaki P, Moradi Bidhendi, Alginate nanoparticles as a promising adjuvant and vaccine delivery system, Indian J Pharm Sci 2013; 75(4):442-449; PMID:24302799; http://dx.doi.org/10.4103/0250-474X.119829.
  • Ouchterlony O. Diffusion-in-gel methods for immunological analysis. II. Prog Allergy 1962; 6:30-154; PMID:14482809.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.